Cancer Letters
Volume 222, Issue 1 , Pages 95-105 , 10 May 2005

Analysis of the cellular and molecular mechanisms of trophic action of a misspliced form of the type B cholecystokinin receptor present in colon and pancreatic cancer

Received 20 May 2004 ,Revised 5 August 2004 ,Accepted 2 September 2004.

References 

  1. Nagata A, Ito M, Iwata N, Kuno J, Takano H, Minowa O, et al. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl Acad. Sci. USA. 1996;93:11825–11830
  2. Baldwin GS. The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth. J. Gastroenterol. Hepatol. 1995;10:215–232
  3. Smith JP, Kramer ST, Solomon TE. CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium. Regul. Pept. 1991;32:341–349
  4. Todisco A, Takeuchi Y, Urumov A, Yamada J, Stepan VM, Yamada T. Molecular mechanisms for the growth factor action of gastrin. Am. J. Physiol. Gastrointest. Liver Physiol. 1997;273:G891–G898
  5. Dabrowski A, Detjen KM, Logsdon CD, Williams JA. Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells. Digestion. 1997;58:361–367
  6. Stepan VM, Dickinson CJ, Del Valle J, Matsushima M, Todisco A. Cell type-specific requirement of the MAPK pathway for the growth factor action of gastrin. Am. J. Physiol. Gastrointest. Liver Physiol. 1999;276:G1363–G1372
  7. Dehez S, Daulhac L, Kowalski-Chauvel A, Fourmy D, Pradayrol L, Seva C. Gastrin-induced DNA synthesis requires p38-MAPK activation via PKC/Ca2+ and Src-dependent mechanisms. FEBS Lett. 2001;496:25–30
  8. Detjen K, Yule D, Tseng MJ, Williams JA, Logsdon CD. CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells. Am. J. Physiol. Cell Physiol. 1997;273:C1449–C1457
  9. Upp JR, Singh P, Townsend CM, Thompson JC. Clinical significance of gastrin receptors in human colon cancers. Cancer Res. 1989;49:488–492
  10. Smith JP, Rickabaugh CA, McLaughlin PJ, Zagon IS. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 1993;265:G149–G155
  11. Smith JP, Stock EA, Wotring MG, McLaughlin PJ, Zagon IS. Characterization of the CCK-B/gastrin-like receptor in human colon cancer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1996;271:R797–R805
  12. Weinberg DS, Ruggeri B, Barber MT, Biswas S, Miknyocki S, Waldman SA. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J. Clin. Invest. 1997;100:597–603
  13. Hellmich MR, Rui XL, Hellmich HL, Fleming RYD, Evers BM, Townsend CM. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J. Biol. Chem. 2000;275:32122–32128
  14. Ding WQ, Kuntz SM, Miller LJ. A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced cellular U2AF35 and a suboptimal 3′-splicing site leading to retention of the fourth intron. Cancer Res. 2002;62:947–952
  15. Smith JP, Verderame MF, McLaughlin P, Martenis M, Ballard E, Zagon IS. Characterization of the CCK-C (cancer) receptor in human pancreatic cancer. Int. J. Mol. Med. 2002;10:689–694
  16. Holicky EL, Hadac EM, Ding XQ, Miller LJ. Molecular characterization and organ distribution of type A and B cholecystokinin receptors in cynomolgus monkey. Am. J. Physiol. Gastrointest. Liver Physiol. 2001;281:G507–G514
  17. Hadac EM, Ghanekar DV, Holicky EL, Pinon DI, Dougherty RW, Miller LJ. Relationship between native and recombinant cholecystokinin receptors-role of differential glycosylation. Pancreas. 1996;13:130–139
  18. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 1980;107:220–239
  19. Gaisano HY, Klueppelberg UG, Pinon DI, Pfenning MA, Powers SP, Miller LJ. Novel tool for the study of cholecystokinin-stimulated pancreatic enzyme secretion. J. Clin. Invest. 1989;83:321–325
  20. Cheng ZJ, Harikumar KG, Holicky EL, Miller LJ. Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth. J. Biol. Chem. 2003;278:52972–52979
  21. Harikumar KG, Pinon DL, Wessels WS, Prendergast FG, Miller LJ. Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor. J. Biol. Chem. 2002;277:18552–18560
  22. Song I, Brown DR, Wiltshire RN, Gantz I, Trent JM, Yamada T. The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc. Natl Acad. Sci. USA. 1993;90:9085–9089
  23. Roettger BF, Rentsch RU, Pinon D, Holicky E, Hadac EM, Larkin JM, et al. Dual pathways of internalization of the cholecystokinin receptor. J. Cell Biol. 1995;128:1029–1042
  24. Rozengurt E, Walsh JH. Gastrin, CCK, signaling, and cancer. Annu. Rev. Physiol. 2001;63:49–76
  25. Berridge MJ, Bootman MD, Lipp P. Calcium—a life and death signal. Nature. 1998;395:645–648
  26. Akagi K, Nagao T, Urushidani T. Calcium oscillations in single cultured Chinese hamster ovary cells stably transfected with a cloned human cholecystokinin (CCK)B receptor. Jpn. J. Pharmacol. 1997;75:33–42
  27. Akagi K, Nagao T, Urushidani T. Correlation between Ca(2+) oscillation and cell proliferation via CCK(B)/gastrin receptor. Biochim. Biophys. Acta. 1999;1452:243–253

☆ This work was supported by grants from the National Institutes of Health, DK32878, the Fiterman Foundation, and by the Kendall-Mayo Fellowship Award (Z.-J.C.).

PII: S0304-3835(04)00713-X

doi: 10.1016/j.canlet.2004.09.008

Cancer Letters
Volume 222, Issue 1 , Pages 95-105 , 10 May 2005

Article Tools

* Image Usage & Resolution